Capricor Therapeutics faces high regulatory risks for its DMD therapy. Get expert analysis on trial data and FDA challenges.

Get a weekly update with in-depth news, analysis and reporting on serious crashes on Long Island’s roads. Read previous newsletter editions here. A Connecticut developer's pitch, though lacking in ...